Drug Profile
Research programme: gonadotrophin releasing hormone antagonists - AbbVie/Neurocrine
Alternative Names: GnRH antagonists - Neurocrine BiosciencesLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Neurocrine Biosciences
- Developer AbbVie; Neurocrine Biosciences
- Class Diamines
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Benign prostatic hyperplasia; Cancer